Evidence map›Paper›PMID 40612548›Full record

ArticleMatrix biology plus2025

Proteomic characterization of type I collagen N-terminal crosslinked peptides.

Zsuzsanna Darula, Maxwell C McCabe, Alex Barrett, Lauren R Schmitt, Mark D Maslanka, Anthony J Saviola, Joseph Orgel, Alma Burlingame, Claudia A Staab-Weijnitz, Kurt Stenmark and 3 more

Abstract read
In one paragraph

Article in Matrix biology plus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Zsuzsanna DarulaSingle Cell Omics Advanced Core Facility, Hungarian Centre of Excellence for Molecular Medicine, Szeged, Hungary.
Maxwell C McCabeDepartment of Biochemistry and Molecular Genetics, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA.
Alex BarrettDepartment of Biochemistry and Molecular Genetics, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA.
Lauren R SchmittDepartment of Biochemistry and Molecular Genetics, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA.
Mark D MaslankaDepartment of Biochemistry and Molecular Genetics, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA.
Anthony J SaviolaDepartment of Biochemistry and Molecular Genetics, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA.
Joseph OrgelDepartment of Biological, Chemical, and Physical Sciences, Illinois Institute of Technology, Chicago, IL USA.
Alma BurlingameDepartment of Pharmaceutical Chemistry, University of California San Francisco, School of Pharmacy, CA, USA.
Claudia A Staab-WeijnitzDepartment of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Kurt StenmarkDepartment of Pediatrics and Cardiovascular Pulmonary Research Laboratory, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Valerie WeaverDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA.
Robert J ChalkleyDepartment of Pharmaceutical Chemistry, University of California San Francisco, School of Pharmacy, CA, USA.
Kirk C HansenDepartment of Biochemistry and Molecular Genetics, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA.

Funding

Tissue mechanics reprograms the tissue to malignancy and metastasisR35CA242447 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VALERIE MARIE WEAVER · 2020 to 2026
$6.6M
Antidepressant regulation of PDACU01CA300847 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Sarah Monica Knox, VALERIE MARIE WEAVER · 2025 to 2026
$1.4M
NCI NIH HHS R35 CA242447NCI NIH HHS U01 CA300847
6 · The paper itself

Abstract

Collagen cross-links mediated by the lysyl oxidase and lysyl hydroxylase families of enzymes significantly contribute to the biomechanical strength and rigidity of tissues, influencing cell signaling and the downstream cell phenotype. In the clinic, the proteolytically liberated N-terminal cross-linked peptide of collagen I (NTX) is used as a biomarker of bone and connective tissue turnover, which is altered in several disease processes. Despite the clinical utility of these collagen breakdown products, the majority of the cross-linked peptide species have not been identified in proteomic datasets. Here, we evaluate several parameters for the preparation and identification of these peptides from the collagen I-rich Achilles tendon. Our refined approach, which involves chemical digestion for protein solubilization coupled with mass spectrometry, enables the identification of NTX cross-links in a range of modification states. We then applied a spectral library approach to identify differences in collagen cross-links in bovine pulmonary hypertension. The presented method offers unique opportunities to understand extracellular matrix remodeling events in development, aging, wound healing, and fibrotic disease that modulate collagen architecture through lysyl hydroxylase and lysyl oxidase enzymes.

Indexed as

CollagenCross-linkingLysyl oxidaseMass spectrometryProteomicsSpectral libraryTelopeptides

Identifiers

PMID40612548
PMCPMC12216727

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.